| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11:06 | EQVA Q2 2026 slides: margin recovery starts as data center push gains | ||
| 11:06 | Tritax Big Box directors subscribe for 771,195 shares at £1.64 | ||
| 11:06 | Magnora Q2 2026 slides: data center growth offsets earnings miss | ||
| 11:06 | VanEck declares dividends for 10 UCITS ETFs | ||
| 11:06 | UBS raises Box stock price target to $37 on revenue acceleration | ||
| 10:54 | DEME H1 2026 slides: record results, strong cash flow amid transition | ||
| 10:54 | Sleep Cycle Q2 2026 slides: B2B pivot gains traction amid consumer pressure | ||
| 10:42 | Rockfire Resources grants 400m share options to directors | ||
| 10:42 | BioArctic Q2 2026 slides: Leqembi growth, Lilly deal offset near-term loss | ||
| 10:42 | Churchill China names James Roper as new CEO | ||
| 10:42 | Piper Sandler upgrades Neogen stock rating on turnaround progress | ||
| 10:42 | Piper Sandler cuts Trupanion stock rating on macro headwinds | ||
| 10:42 | Bernstein SocGen cuts Strategy stock price target on Bitcoin outlook | ||
| 10:30 | SoftwareONE H1 2026 slides: margin surge, synergies ahead of plan | ||
| 10:30 | Magnora Data Center H1 2026 slides: 650 MW portfolio post-IPO | ||
| 10:30 | Hammerson sets ZAR exchange rate for interim dividend payment | ||
| 10:30 | Gurit H1 2026 slides: margin doubles as strategic realignment delivers | ||
| 10:30 | UBS upgrades argenx stock rating on Vyvgart sales outlook | ||
| 10:30 | Deutsche Bank raises Jazz Pharmaceuticals stock price target on FDA approval | ||
| 10:06 | BofA reiterates Nvidia stock rating on supply commitment strategy | ||
| 10:06 | Wolfe Research reiterates SpaceX stock rating on launch expansion | ||
| 09:42 | Nxera to receive $10m milestone as partner's Alzheimer's drug enters phase 2 | ||
| 09:42 | Santander admits 329.8 million shares to London trading | ||
| 09:42 | Nordic Aqua Q2 2026 slides: record harvest, China premium pricing | ||
| 09:18 | B.Riley initiates Cardiol Therapeutics stock with buy rating on pericarditis drug potential |